EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo Evaluation of the Effect of Limosilactobacillus fermentum MC1 and Its EPSs on the Microbiota and Inflammatory Processes in the Mouse Intestine

Nina Čuljak iD, Nada Oršolić iD, Dyana Odeh iD, Andreja Leboš Pavunc iD, Katarina Butorac iD, Martina Banić, Jasna Novak iD, Kate Šešelja iD, Mirela Baus Lončar, Snježana Ramić iD, Tanja Jurkin, Jagoda Šušković iD und 1 weitere

International Journal of Molecular Sciences · 01.03.2026 · 27 (5) · 2321

DOI: 10.3390/ijms27052321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2026. Verfasst von Nina Čuljak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Engineering, University of Zagreb Faculty of Food Technology and Biotechnology, Pierottijeva 6, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Limosilactobacillus fermentum, Colitis, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, University of Zagreb, Croatia, Scientific Centre of Excellence for Marine Bioprospecting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limosilactobacillus fermentum MC1 is an exopolysaccharide (EPS)-producing strain with previously determined probiotic potential in vitro. This study aimed to investigate the in vivo capacity of the MC1 strain or its EPSs to modulate intestinal microbiota and assess its anti-inflammatory effects in both healthy and dysbiotic conditions. Therefore, Lb. fermentum MC1 and its EPSs were administered to a mouse model of dextran sulfate sodium (DSS)-induced colitis (DIC) and to a healthy group, and the effects were observed. Microbiome analysis was used to detect taxonomic differences between treatments. According to the results, administration of the MC1 strain and MC1-EPSs significantly altered gut microbiome composition at different taxonomic levels. The most notable effect was an increased relative abundance of Firmicutes and decreased levels of Candidatus saccharibacteria. Llb. fermentum MC1, and its EPS administration positively affected several disease parameters: reduced disease activity index (DAI), reduced mouse colitis histology index (MCHI), reduced expression of inflammation-related genes and levels of bleeding, and induced polarization of M1 macrophages to the M2-like macrophage phenotype in the DIC mice. These results, along with those related to the induction of antioxidant enzymes and changes in NF-κB-related gene expression, suggest that strain MC1 and MC1-EPSs could be further investigated for their capacity to alleviate DSS-induced histopathological changes and modulate pro-inflammatory cytokine gene expression in colon tissue, which positively correlates with the secretion of inflammatory cytokines, the delay of intestinal inflammation and the maintenance of intestinal barrier function. The obtained data provide a basis for further research into the potential application of intact or microencapsulated Llb. fermentum MC1 cells and its EPSs in colitis therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Limosilactobacillus fermentumColitisGastrointestinal MicrobiomeProbioticsInflammationPolysaccharides, BacterialAnimalsMiceDextran SulfateDisease Models, AnimalIntestinesMaleMacrophages

Stichwörter der Autor:innen

Limosilactobacillus fermentumanti-inflammatory propertiesencapsulation deliveryexopolysaccharidesmicrobiota

Substanzen

Dextran SulfatePolysaccharides, Bacterial

Autor:innen und Institutionen

  • Department of Biochemical Engineering, University of Zagreb Faculty of Food Technology and Biotechnology, Pierottijeva 6, 10000 Zagreb, Croatia.
  • Division of Animal Physiology, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.
  • Department of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia.
  • Department of Oncological Pathology, Clinical Hospital for Tumors, Sestre Milosrdnice University Hospital Centre, Ilica 197, 10000 Zagreb, Croatia.
  • Radiation Chemistry and Dosimetry Laboratory, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia.

ORCID-Profile: Nina Čuljak, Nada Oršolić, Dyana Odeh, Andreja Leboš Pavunc, Katarina Butorac, Jasna Novak, Kate Šešelja, Snježana Ramić, Jagoda Šušković, Blaženka Kos

Förderung

  • Croatian Science Foundation
  • University of Zagreb, Croatia
  • Scientific Centre of Excellence for Marine Bioprospecting
  • FEMS Research and Training Grant

Zitieren

APA

Čuljak, N., Oršolić, N., Odeh, D., Leboš Pavunc, A., Butorac, K., Banić, M., Novak, J., Šešelja, K., Baus Lončar, M., Ramić, S., Jurkin, T., Šušković, J., & Kos, B. (2026). In Vivo Evaluation of the Effect of Limosilactobacillus fermentum MC1 and Its EPSs on the Microbiota and Inflammatory Processes in the Mouse Intestine. International Journal of Molecular Sciences, 27(5), 2321. https://doi.org/10.3390/ijms27052321

Vancouver

Čuljak N, Oršolić N, Odeh D, Leboš Pavunc A, Butorac K, Banić M, et al. In Vivo Evaluation of the Effect of Limosilactobacillus fermentum MC1 and Its EPSs on the Microbiota and Inflammatory Processes in the Mouse Intestine. International Journal of Molecular Sciences. 2026;27(5):2321. doi:10.3390/ijms27052321

BibTeX
@article{uljak2026,
  author = {Čuljak, Nina and Oršolić, Nada and Odeh, Dyana and Leboš Pavunc, Andreja and Butorac, Katarina and Banić, Martina and Novak, Jasna and Šešelja, Kate and Baus Lončar, Mirela and Ramić, Snježana and Jurkin, Tanja and Šušković, Jagoda and Kos, Blaženka},
  title = {In Vivo Evaluation of the Effect of Limosilactobacillus fermentum MC1 and Its EPSs on the Microbiota and Inflammatory Processes in the Mouse Intestine},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2321},
  doi = {10.3390/ijms27052321}
}
Kostenlos starten →